Dexlansoprazole
右兰索拉唑
Report date: 2026/05/21 20:00:22
NME
Base Information
Drug NameDexlansoprazole
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2009/01/30
Country/Territory +[26]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of KarachiTakeda Pharmaceuticals USA IncJiangsu Hansoh Pharmaceutical Group Co Ltd +[9]
Inactive CompaniesTakeda Pharmaceutical Co Ltd Osaka PlantTakeda (Thailand), LtdUniversity Of North Carolina At Chapel Hill +[11]
Active Indications +[6]
Inactive Indications +[5]